Abbvie Inc. vs The Cooper Companies, Inc.
ABBV vs COO — side-by-side comparison from reported financials. ABBV leads 6, COO leads 5 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
The Cooper Companies, Inc.
COO · Healthcare
$54.37+0.13%Strained
| Metric | ABBV | COO |
|---|---|---|
| Price | $276.43 | $54.37 |
| Market cap | $488B | $10.3B |
| Revenue (TTM) | $64.4B | $4.24B |
| Revenue growth | +1.8% | +7.3% |
| Net margin | 9.8% | 13.5% |
| Free cash flow | $18.2B | $678M |
| Net cash (debt) | ($56.2B) | ($2.39B) |
| 1-year price return | +19.8% | -22.1% |
| P/E | 77.4 | 18.1 |
| P/E vs own history (cheap-side %) | 23% | 89% |
| Dividend yield | 2.45% | 0.00% |
| Return on equity | 96% | 7% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 15,000 |
Full résumé-style profiles: ABBV CV · COO CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.